The "Commentary" by Rothrock et al 1 includes a critique of our Systematic Review 2 and Letter. 3 They also introduce a misleading account of ivermectin safety and proposals for individual participant data (IPD) in meta-analysis that are impractical in a health emergency. We respond to the various matters in turn.